Evidence map›Paper›PMID 37129759›Full record

ReviewCurrent cardiology reports2023

3D Printing Approaches to Engineer Cardiac Tissue.

Ting-Yu Lu, Yi Xiang, Min Tang, Shaochen Chen

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current cardiology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Contribution of the ELRs to the development of advancedFrontiers in bioengineering and biotechnology · 2024
    Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ting-Yu LuMaterials Science and Engineering Program, University of California, 9500 Gilman Dr. San Diego, 92093, La Jolla, CA, USA.
Yi XiangDepartment of NanoEngineering, University of California, 9500 Gilman Dr. San Diego, 92093, La Jolla, CA, USA.
Min TangDepartment of NanoEngineering, University of California, 9500 Gilman Dr. San Diego, 92093, La Jolla, CA, USA.
Shaochen ChenMaterials Science and Engineering Program, University of California, 9500 Gilman Dr. San Diego, 92093, La Jolla, CA, USA. chen168@eng.ucsd.edu.
University of California, San Diego · US

Funding

Studying Nanotoxicity Using Bioprinted Human Liver TissuesR21ES034455 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, SHAOCHEN · 2022 to 2023
$398k
NIEHS NIH HHS R21 ES034455
6 · The paper itself

Abstract

purpose of reviewBioengineering of functional cardiac tissue composed of primary cardiomyocytes has great potential for myocardial regeneration and in vitro tissue modeling. 3D bioprinting was developed to create cardiac tissue in hydrogels that can mimic the structural, physiological, and functional features of native myocardium. Through a detailed review of the 3D printing technologies and bioink materials used in the creation of a heart tissue, this article discusses the potential of engineered heart tissues in biomedical applications. RECENT

findingsIn this review, we discussed the recent progress in 3D bioprinting strategies for cardiac tissue engineering, including bioink and 3D bioprinting methods as well as examples of engineered cardiac tissue such as in vitro cardiac models and vascular channels. 3D printing is a powerful tool for creating in vitro cardiac tissues that are structurally and functionally similar to real tissues. The use of human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) enables the generation of patient-specific tissues. These tissues have the potential to be used for regenerative therapies, disease modeling, and drug testing.

Indexed as

Induced Pluripotent Stem CellsMyocardiumHumansMyocytes, CardiacPrinting, Three-DimensionalTissue EngineeringTissue Scaffolds3D printingBioinkTissue engineeringTissue modeling

Identifiers

PMID37129759
PMCPMC10152016
OpenAlexW4367669376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.